BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25651470)

  • 41. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
    Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
    Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A New Hitherto Unreported Histopathologic Manifestation of Mammary Analogue Secretory Carcinoma: "Masked MASC" Associated With Low-grade Mucinous Adenocarcinoma and Low-grade In Situ Carcinoma Components.
    Petersson F; Michal M; Kazakov DV; Grossmann P; Michal M
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):e80-e85. PubMed ID: 26808131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
    Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
    Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
    Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
    Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary mammary analogue secretory carcinoma of the lung: a case report.
    Huang T; McHugh JB; Berry GJ; Myers JL
    Hum Pathol; 2018 Apr; 74():109-113. PubMed ID: 29104113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
    Xu B; Haroon Al Rasheed MR; Antonescu CR; Alex D; Frosina D; Ghossein R; Jungbluth AA; Katabi N
    Histopathology; 2020 Feb; 76(3):375-382. PubMed ID: 31448442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases in the lips.
    Kratochvil FJ; Stewart JC; Moore SR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):630-5. PubMed ID: 23021923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.
    Skalova A
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S30-6. PubMed ID: 23821207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent Identification of Novel EGFR-SEPT14 Fusion and ETV6-RET Fusion in Secretory Carcinoma of the Salivary Gland.
    Black M; Liu CZ; Onozato M; Iafrate AJ; Darvishian F; Jour G; Cotzia P
    Head Neck Pathol; 2020 Sep; 14(3):817-821. PubMed ID: 31502214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of novel genetic alterations in salivary gland secretory carcinoma.
    Na K; Hernandez-Prera JC; Lim JY; Woo HY; Yoon SO
    Mod Pathol; 2020 Apr; 33(4):541-550. PubMed ID: 31822803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammary analogue secretory carcinoma mimicking salivary adenoma.
    Williams L; Chiosea SI
    Head Neck Pathol; 2013 Dec; 7(4):316-9. PubMed ID: 23620147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
    Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
    Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rare malignancy of the parotid gland in a 13-year-old Taiwanese boy: case report of a mammary analogue secretory carcinoma of the salivary gland with molecular study.
    Hwang MJ; Wu PR; Chen CM; Chen CY; Chen CJ
    Med Mol Morphol; 2014 Mar; 47(1):57-61. PubMed ID: 23955668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein).
    Laco J; Švajdler M; Andrejs J; Hrubala D; Hácová M; Vaněček T; Skálová A; Ryška A
    Pathol Res Pract; 2013 Mar; 209(3):167-72. PubMed ID: 23357688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammary analog secretory carcinoma of thyroid: A case report.
    Rupp AP; Bocklage TJ
    Diagn Cytopathol; 2017 Jan; 45(1):45-50. PubMed ID: 27633961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics.
    Luk PP; Selinger CI; Eviston TJ; Lum T; Yu B; O'Toole SA; Clark JR; Gupta R
    Pathology; 2015 Dec; 47(7):659-66. PubMed ID: 26517645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
    Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
    Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.